🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

22 recruiting trials

for Carcinoma, Adenoid Cystic

Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation NCT04214366Phase 21 site📍 Heidelberg Heidelberg University · Tests: Carbon ion irradiation, Bimodal irradiation Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer NCT07667400Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: SX-682, DTX A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Recurrent Sinonasal Adenoid Cystic Carcinoma NCT07522879Phase 21 site📍 Shanghai Eye & ENT Hospital of Fudan University · Tests: Becotatug Vedotin Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants NCT00898638n/a4 sites📍 Nashville📍 Nashville📍 Nashville Vanderbilt University Medical Center · Tests: biologic sample preservation procedure, medical chart review A Multi-omics Approach to Disclose Progression and Underlying Biology of Head and Neck Adenoid Cystic Carcinoma NCT07507578n/a1 site📍 Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Tests: Standard of Care (Investigator Choice) CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC NCT05774899Phase 1, Phase 21 site📍 Boston Michael J. Dennis, MD · Tests: CB-103, Abemaciclib, Lenvatinib A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit NCT06805825Phase 15 sites📍 Ann Arbor📍 Cleveland📍 Portland Novelty Nobility, Inc. · Tests: NN3201 First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor NCT07755397Phase 16 sites📍 Surat📍 Bangalore📍 Mumbai Jubilant Therapeutics India Limited · Tests: JBI-778 Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma: A Prospective Observational Study NCT07652489n/a6 sites📍 Harbin📍 Changsha📍 Shenyang Eye & ENT Hospital of Fudan University · Tests: Surgery Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma NCT06118086Phase 1, Phase 29 sites📍 San Francisco📍 Tampa📍 Boston Remix Therapeutics · Tests: REM-422 A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers NCT06805617Phase 22 sites📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: Ivonescimab Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors NCT02838602NA21 sites📍 Amiens📍 Caen📍 Clermont-Ferrand Hospices Civils de Lyon · Tests: Carbon ions therapy, Advanced external radiotherapy by Xrays or protons Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I) NCT07162480Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: P-Sam A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors NCT05377996Phase 1, Phase 226 sites📍 Phoenix📍 Orange📍 San Francisco Day One Biopharmaceuticals, Inc. · Tests: Emi-Le A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma NCT06891560Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Enfortumab Vedotin Clinical Trial of HG146 Administered to Participants With Adenoid Cystic Carcinoma NCT06781567Phase 21 site📍 Shanghai HitGen Inc. · Tests: HG146 Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial NCT04883671NA5 sites📍 San Francisco📍 Chicago📍 Boston Dana-Farber Cancer Institute · Tests: Standard of Care, SBRT Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck NCT01473784NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: transoral robotic surgery, quality of life assessment VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites📍 Santa Rosa📍 Hartford📍 Washington D.C. VM Oncology, LLC · Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers NCT05553782EARLY Phase 12 sites📍 Boston📍 Boston Brigham and Women's Hospital · Tests: Implantable Microdevice (IMD) Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic Carcinoma NCT05733910NA1 site📍 Pavia CNAO National Center of Oncological Hadrontherapy · Tests: simultaneous integrated boost of carbon ions radiation therapy Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study NCT07320508Phase 21 site📍 Shanghai Eye & ENT Hospital of Fudan University · Tests: Epirubicin (E)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy